Oncology

Oncology is a core therapeutic area for PRORELIX RESEARCH and as such brings a wide-ranging depth of expertise.

CNS – Including Pain & Psychiatry

The volume of research into new therapies for central nervous system (CNS) diseases is increasing to meet the needs of the …

Autoimmune / Inflammation

Autoimmune and Inflammatory diseases such as Rheumatoid Arthritis (RA), Crohn’s Disease and Ulcerative Colitis (UC)…

Therapeutic Expertise
Cardiovascular

PRORELIX has a tradition of delivering clinical research projects of both drugs and medical devices for the treatment of cardiovascular disease.

Opthalmology

When you are developing products for the eye, you need specialist experience and expertise. You might also need a greater breadth of services and geographical ghgfhfghg…

Endocrinology / Diabetology

The incidence of diabetes and obesity are increasing on a global scale and PRORELIX RESEARCH is playing a significant role in supporting…

Oncology


Oncology is a core therapeutic area for PRORELIX RESEARCH and as such brings a wide-ranging depth of expertise. PRORELIXRESEARCH has been operating the clinical trials in a variety of oncology indications, across all age groups in INDIA since its inception. Our track record has provided a unique reputation for high quality and on-time delivery in the area of oncology.
PRORELIX RESEARCH’s oncology experience includes studies of new medicines and medical devices involving hundreds of subjects performed both in adult and pediatric populations. We have experience in conducting studies in various cancer types including, but not limited to:

  • AML
  • Colorectal
  • Head and Neck
  • Hepatic Tumour
  • Multiple myeloma
  • Prostate Cancer
  • Renal cell carcinoma
  • Supportive care
  • Breast cancer
  • Ovarian cancer
  • Prostate cancer

CNS – Including Pain & Psychiatry


The volume of research into new therapies for central nervous system (CNS) diseases is increasing to meet the needs of the increasing age of the global population.
Over the years, WE have involved and managed many trials of CNS therapies, creating an extensive network of academic and private practice investigators in neurology, psychiatry, pain, sleep disorders and other neurological areas (i.e. image contrast agents).
We have also developed close relationships with international CNS experts / Key Opinion Leaders. This enables us to provide specialized related services such as management of the standardization of the evaluation of the cognitive function (rater reliability) or the expert management and central review of diagnostic images used in CNS research.
PRORELIX RESEARCH’s CNS experience includes biopharmaceutical projects in stages from Phase II through Registry, performed both in adult and pediatric populations, in a broad range of indications, including but not limited to:

  • Alzheimer’s Disease
  • Amyotrophic Lateral Sclerosis
  • Anxiety
  • Depression
  • Dementia
  • Epilepsy
  • Fibromyalgia
  • Huntington’s chorea
  • Insomnia
  • Mild Cognitive Impairment
  • Migraine
  • Multiple Sclerosis
  • Parkinson’s Disease
  • Schizophrenia
  • Sleep disorder
  • Stroke

Autoimmune / Inflammation


Autoimmune and Inflammatory diseases such as Rheumatoid Arthritis (RA), Crohn’s Disease and Ulcerative Colitis (UC) affect millions of people each year. Research and development activity in this area is considerable, with many new therapies being clinically evaluated at present.
PRORELIX RESEARCH has significant experience in managing research projects targeting medical conditions in all aspects of the immune system including autoimmune diseases, hypersensitivities, immune deficiency and transplant rejection.
We have professionals on board who are experienced in Immunology and Inflammation trials in a broad range of indications, including but not limited to:

  • Allergies
  • Ankylosingspondylitis
  • Chronic pain
  • Cystic fibrosis
  • Gout
  • HIV
  • Immune deficiency
  • Lupus
  • Osteoarthritis
  • Psoriatic arthritis
  • Rheumatoid arthritis
  • Ulcerative colitis
  • Vaccine therapy

Cardiovascular


PRORELIX has a tradition of delivering clinical research projects of both drugs and medical devices for the treatment of cardiovascular disease.
Over the years, PRORELIX has involved in various projects in a broad range of cardiovascular indications, including but not limited to:

  • Acute Myocardial Infarction
  • Acute decompensated heart failure
  • Aortic Valve Replacement
  • Atherosclerosis
  • Atrial Fibrillation
  • Carotid Artery Disease
  • ClaudicationIntermittens
  • Coagulation
  • Coronary Heart disease
  • Coronary Artery Disease
  • Deep Vein Thrombosis
  • Heart Block
  • Heart Insufficiency
  • Hypertension
  • Implanted Nerve Stimulator
  • Ischemic heart disease
  • Myocardial infarction
  • Hypertension
  • Peripheral Vascular Lesions
  • Peripheral Artery Occlusion disease
  • Pulmonary Arterial Hypertension
  • Vascular Imaging
  • Vascular Surgery
  • Venous Insufficiency

Opthalmology


When you are developing products for the eye, you need specialist experience and expertise. You might also need a greater breadth of services and geographical coverage than small niche CROs can provide. PRORELIX RESEARCHcombines the best aspects of a niche ophthalmology CRO with the stability and comprehensive in-house capabilities of a leading mid-size, full-service international CRO. Our geographic reach extends internationally, and our experienced team will expertly support your project in all applicable countries.

PRORELIX RESEARCH’S has broad experience across many indications resulting from the delivery of many ophthalmology trials and from the legacy experience of our team. Many trials in ophthalmology are complex, and for this reason you need a team which understands the assessments and can focus on the details. The team at PRORELIX RESEARCH has this experience, indeed many of them have worked in ophthalmology in the clinical setting. This means that they not only check, but also interpret and understand your research data as it is being collected. Our team also knows how Ophthalmology sites work, and how best to manage and support them to ensure rapid recruitment and high quality data. With an expert and stable team committed to reaching your goals, supported by experienced international teams in functions including regulatory, biometrics, safety and quality selecting PRORELIX RESEARCH gives your product the best chance of success.

Endocrinology / Diabetology


The incidence of diabetes and obesity are increasing on a global scale and PRORELIX RESEARCH is playing a significant role in supporting development of new therapies to treat these types of chronic metabolic disorders.
We have deep experience and expertise not only in recruiting specialized patient populations, but also in retaining them for longer term studies.
PRORELIX’s Endocrinology and Diabetes experience includes over many studies indifferentPhases through Registry and with Medical Devices IDE and non-IDE stages. Specifically, we have completed studies in a wide range of conditions including but not limited to

  • Hyperparathyroidism
  • Type I Diabetes
  • Type II Diabetes
  • Obesity

Significantly we have also completed several studies including pediatric subjects in this therapy area. Through our endocrinology expertise, PRORELIX becomes your trusted partner and adds immediate value to your project.

Respiratory – A Challenging Area


Reversibility testing, extensive run-in treatment periods, repeated serial spirometry, home-based PEF monitoring, symptom diaries, exacerbation capture, large subject recruitment requirements…

Clinical research in respiratory medicine has many unique challenges. That is why you need a partner with experience and expertise, to advise you on the best project plan, and then to deliver that plan on time and to the original budget.
Success in respiratory projects can only be achieved on the foundation of a detailed and expert feasibility analysis. Through our proven Feasibility criteria, PRORELIX RESEARCH identities the optimal country and site mix for your particular study. This is the basis for accurate planning and the key to success in meeting the originally agreed project timelines within the originally agreed budget.

PRORELIX RESEARCH has an extensive international network of proven high-quality investigator sites, and has developed close relationships with many KOLs across ASIA, Europe and USA. In addition to outstanding expertise in respiratory project design and management, PRORELIX RESEARCH also has long-standing relationships with third party vendors whose products support work in this field.
Our work in Respiratory Medicine includes, but is not limited to, the following indications:

  • Acute and Chronic Sinusitis
  •  Allergic Rhinitis
  • Asthma (mild to severe – drug and medical device)
  • COPD
  • Lung Cancer
  • Rhino sinusitis
  • Smoking Cessation
  • Upper and Lower Respiratory Tract Infections

Gastrointestinal


Clinical drug development for digestive disorders and diseases, such as inflammatory bowel disease and functional GI disorders, presents a unique set of challenges for developing new and effective treatments.
PRORELIX RESEARCH has extensive experience in conducting gastrointestinal studies across the entire drug development spectrum, ranging from the initial studies in Phase II through post-marketing efforts in Phase IV.
Our clinical trial experience includes but is not limited to the following gastrointestinal indications:

  • Acute Pancreatitis
  • Ascites
  • Biliary Duct Stenosis
  • Colorectal Conditions
  • Constipation
  • Crohn’s Disease
  • Liver Cirrhosis
  • Exocrine pancreatic insufficiency in cystic fibrosis
  • Inflammatory Bowel Disease
  • Irritable Bowel Disease
  • Gastroenteritis Infections
  • Pancreatic cancer
  • Ulcerative Colitis

Other Therapeutic Areas:


PRORELIX RESEARCH’s overall therapeutic expertise includes the management of pharmaceutical trials in a variety of rare disease indications (Nephrology &Urology, Hematology, Vaccines, HIV, Women Health). With proven expertise in finding and recruiting the right patients to these challenging studies, PRORELIXRESEARCH supports such projects with our trusted methodology, which involves detailed project planning, protocol assessment, logistical analysis and the execution of all aspects of your clinical trial.

Most often, the major challenges inherent in completion of studies in these areas result from a limited patient population with a wide geographical spread. In order to address these challenges, the first step is to conduct a thorough feasibility analysis. With our Feasibility approach, PRORELIX RESEARCH is able to not only identify and quantify the available patient population but also to expertly examine other key facets of the project, such as the clinical acceptability of the protocol, the availability and experience of the investigators, the existence of competing research, and the applicable regulatory landscape of each potential country. These data are iteratively analysed to create various operational strategies, providing our clients with reliable overall timelines and budgets for each scenario. When feasibility is so crucial to success, it makes sense to work with PRORELIX RESEARCH, the industry leaders in feasibility and trial planning.

  • Acute Pancreatitis
  • Ascites
  • Biliary Duct Stenosis
  • Colorectal Conditions
  • Constipation
  • Crohn’s Disease
  • Liver Cirrhosis
  • Exocrine pancreatic insufficiency in cystic fibrosis
  • Inflammatory Bowel Disease
  • Irritable Bowel Disease
  • Gastroenteritis Infections
  • Pancreatic cancer
  • Ulcerative Colitis
Enquire Now